NOTE TO FILE
DocuSign Envelope ID: 87942F23-C956-4338-83D5-5C90DA1192FE
NOTE TO FILE
Datum: 18 Februari 2022
Avtalsnummer: SAMORG 2021014
Avtal för uppdrag med patientorganisation
Avtalsförnyelse på grund av förkommit originalavtal
Avtal SAMORG 2021014 upprättades för att Roche har för avsikt att anordna ett seminarium om patientlagen och dess innebörd för allmänheten, patienter och anhöriga.
Bakgrunden till att Roche vill anlita Konsulten för detta uppdrag är hennes erfarenheter som patient och som representant för NMC Konsulten kommer att delta i en panel och dela med sig av sina erfarenheter om sitt sjukdomsområde och hur patientlagen har tillämpats, vilka utmaningar det finns och hur man kan arbeta vidare inom området. Under webbinariet kommer det finnas möjlighet att ställa frågor till panelen som består av konsulten, patientföreträdare från andra patientföreningar, politiker och representanter från vården.
Då påskrivet avtal endast var giltigt fram till 1 mars och seminariet har flyttats till den 23 mars, förlängs härmed avtalet fram till 23 juni 2022
Signature and date
18 februari 2022
Xxxxxxxxx Xxxx - Nätverket mot cancer
18 February 2022
Xxxxx Xxxxxxx - Ansvarig patientrelationer - Roche
18 februari 2022
Xxxxxx Xxxxxxx - Ansvarig Samhällsrelationer - Roche
Page 1 of 1
Certificate Of Completion
Envelope Id: 87942F23C956433883D55C90DA1192FE Status: Completed Subject: Please DocuSign: Note to File avtalsändring 2021014 NMC.pdf
Source Envelope:
Document Pages: 1 Signatures: 3 Envelope Originator:
Certificate Pages: 4 Initials: 0 Xxxxxxx Xxxxxxxxxxx
AutoNav: Enabled
EnvelopeId Stamping: Enabled
Time Zone: (UTC+01:00) Amsterdam, Berlin, Bern, Rome, Stockholm, Vienna
Xxxxxxxxxxxxxxxxx 000
Basel, Basel-Stadt 4070 xxxxxxx.xxxxxxxxxxx@xxxxx.xxx IP Address: 196.3.50.247
Record Tracking
Status: Original
2/18/2022 11:15:59 AM
Holder: Xxxxxxx Xxxxxxxxxxx xxxxxxx.xxxxxxxxxxx@xxxxx.xxx
Location: DocuSign
Signer Events Signature Timestamp
Xxxxx Xxxxxxx xxxxx.xxxxxxx@xxxxx.xxx
Security Level: Email, Account Authentication (None)
Signature Adoption: Pre-selected Style Using IP Address: 83.250.59.7
Sent: 2/18/2022 11:16:29 AM Viewed: 2/18/2022 3:50:42 PM Signed: 2/18/2022 3:50:50 PM
Electronic Record and Signature Disclosure:
Accepted: 2/18/2022 3:50:42 PM
ID: 52aaecda-2422-44a1-90a9-4435faf4c0f3 Company Name: X. Xxxxxxxx-La Roche Ltd
Xxxxxx Xxxxxxx xxxxxx.xxxxxxx@xxxxx.xxx HCS and innovation coach
Security Level: Email, Account Authentication
(None) Signature Adoption: Pre-selected Style
Using IP Address: 94.234.37.185 Signed using mobile
Sent: 2/18/2022 3:50:51 PM Viewed: 2/18/2022 3:59:32 PM Signed: 2/18/2022 3:59:40 PM
Electronic Record and Signature Disclosure:
Accepted: 2/18/2022 3:59:32 PM
ID: 8d9bff00-65df-4559-84f5-ee9728d6e8d2 Company Name: X. Xxxxxxxx-La Roche Ltd
Xxxxxxxxx Xxxx xxxxxxxxx.xxxx@xxxxxxxxxxxxxxxxxx.xx
Security Level: Email, Account Authentication (None)
Signature Adoption: Pre-selected Style Using IP Address: 78.82.240.14
Sent: 2/18/2022 3:59:41 PM Viewed: 2/18/2022 5:02:50 PM Signed: 2/18/2022 5:03:26 PM
Electronic Record and Signature Disclosure:
Accepted: 2/18/2022 5:02:50 PM
ID: b3e8e1cc-54d3-434a-b372-3233037f814f
Company Name: X. Xxxxxxxx-La Roche Ltd
In Person Signer Events | Signature | Timestamp |
Editor Delivery Events | Status | Timestamp |
Agent Delivery Events | Status | Timestamp |
Intermediary Delivery Events | Status | Timestamp |
Certified Delivery Events | Status | Timestamp |
Carbon Copy Events | Status | Timestamp |
Witness Events | Signature | Timestamp |
Notary Events | Signature | Timestamp |
Envelope Summary Events | Status | Timestamps |
Envelope Sent | Hashed/Encrypted | 2/18/2022 11:16:29 AM |
Certified Delivered | Security Checked | 2/18/2022 5:02:50 PM |
Signing Complete | Security Checked | 2/18/2022 5:03:26 PM |
Completed | Security Checked | 2/18/2022 5:03:26 PM |
Payment Events | Status | Timestamps |
Electronic Record and Signature Disclosure | ||
Electronic Record and Signature Disclosure created on: 1/3/2019 2:16:57 PM Parties agreed to: Xxxxx Xxxxxxx, Xxxxxx Xxxxxxx, Xxxxxxxxx Xxxx
Guidelines for the use of the DocuSign electronic signing system within X. Xxxxxxxx-La Roche and companies of the Roche Group
LEGAL DISCLOSURE
By placing my electronic signature on this document, I expressly consent to use and rely on Electronic and Digital Signatures and I understand my signature will have the same binding effect as if I was providing a handwritten signature.
I also confirm the email address that I am using as a valid one to be notified and identified electronically, for example through the DocuSign System, and/or to identify me as the signer of the document. I should inform Roche in the case that the email address changes.
CONSUMER DISCLOSURE
From time to time, X. Xxxxxxxx-La Roche and companies of the Roche Group (hereinafter referred to as we, us or Company) may be required by law to provide to you certain written notices or disclosures. Described below are the terms and conditions for providing to you such notices and disclosures electronically through the DocuSign, Inc. (DocuSign) electronic signing system. Please read the information below carefully and thoroughly, and if you can access this information electronically to your satisfaction and agree to these terms and conditions, please confirm your consent by clicking the 'I agree' button at the bottom of this document.
Consequences of changing your mind
To indicate to us that you are changing your mind, you must withdraw your consent using the DocuSign 'Withdraw Consent' form on the signing page of a DocuSign envelope instead of signing it. This will indicate to us that you have withdrawn your consent to receive required notices and disclosures electronically from us and you will no longer be able to use the DocuSign system to receive required notices and consents electronically from us or to sign electronically documents from us.
All notices and disclosures will be sent to you electronically
Unless you tell us otherwise in accordance with the procedures described herein, we will provide electronically to you through the DocuSign system all required notices, disclosures, authorizations, acknowledgements, and other documents that are required to be provided or made available to you during the course of our relationship with you. To reduce the chance of you inadvertently not receiving any notice or disclosure, we prefer to provide all of the required notices and disclosures to you by the same method and to the same address that you have given us. If you do not agree with this process, please let us know as described below. Please also see the paragraph immediately above that describes the consequences of your electing not to receive delivery of the notices and disclosures electronically from us.
How to contact us
You may contact us to let us know of your changes as to how we may contact you electronically, to request certain information from us and to withdraw your prior consent to receive notices and disclosures electronically. To do so contact the sender of the envelope.
To advise us of your new email address
To let us know of a change in your email address where we should send notices and disclosures electronically to you, you must send an email message to the sender of the envelope and in the body of such request you must state: your previous email address, your new email address. We do not require any other information from you to change your email address. In addition, you must notify DocuSign, Inc. to arrange for your new email address to be reflected in your DocuSign account by following the process for changing email in the DocuSign system.
To withdraw your consent
To inform us that you no longer want to receive future notices and disclosures in electronic format you may decline to sign a document from within your DocuSign session, and on the subsequent page, select the check-box indicating you wish to withdraw your consent.
Acknowledging your access and consent to receive materials electronically
To confirm to us that you can access this information electronically, which will be similar to other electronic notices and disclosures that we will provide to you, please verify that you were able to read this electronic disclosure and that you also were able to print on paper or electronically save this page for your future reference and access or that you were able to email this disclosure and consent to an address where you will be able to print on paper or save it for your future reference and access. Further, if you consent to receiving notices and disclosures exclusively in electronic format on the terms and conditions described above, please let us know by clicking the 'I agree' button below.
By checking the 'I agree' box, I confirm that:
● I can access and read this Electronic CONSENT TO ELECTRONIC RECEIPT OF ELECTRONIC CONSUMER DISCLOSURES document; and
● I can print on paper the disclosure or save or send the disclosure to a place where I can print it, for future reference and access; and
● Until or unless I notify the account owner as described above, I consent to receive from exclusively through electronic means all notices, disclosures, authorizations, acknowledgements, and other documents that are required to be provided or made available to me by the account owner during the course of my relationship with you.
● I acknowledge the information included in the† DocuSign Privacy Policy